Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole in Biochemically Relapsed Prostate Cancer
NCT01787331Phase 2Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2013
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of itraconazole in prostate adenocarcinoma, sponsored by University of California, San Francisco. Started Oct 2013; status: completed.
02
Drugs
itraconazole
03
Conditions
prostate adenocarcinoma
Beyond the preview
Go deeper on NCT01787331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01787331.